Our preliminary results show that HKDC1 contributes to both endocrine and chemo resistance, and the inhibition of HKDC1 activity by either chemical or biological method significantly suppresses the tumor growth, and this investigation is still in process. Here, HKDC1 is linked to neoplasm.